Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 23 results.
User Information
Export Records
  1. 1.   Glycolytic reprogramming through PCK2 regulates tumor initiation of prostate cancer cells
  2. Zhao, Jiangsha; Li, Jieran; Fan, Teresa W M; Hou, Steven
  3. Oncotarget. 2017, Oct 13; 8(48): 83602-83618.
  1. 2.   Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapy
  2. Su, D. M.; Zhang, Q. Y.; Wang, X. X.; He, P.; Zhu, Y.; Zhao, J. X.; Rennert, O. M.; Su, Y. A.
  3. Molecular Cancer Therapeutics. 2009 8(5): 1292-1304.
  1. 3.   Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer
  2. Michaud, D. S.; Daugherty, S. E.; Berndt, S. I.; Platz, E. A.; Yeager, M.; Crawford, E. D.; Hsing, A.; Huang, W. Y.; Hayes, R. B.
  3. Cancer Research. 2006, Apr; 66(8): 4525-4530.
  1. 4.   Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas
  2. Lo, P. H. Y.; Leung, A. C. C.; Xiong, W. J.; Law, S.; Duh, F. M.; Lerman, M. I.; Stanbridge, E. J.; Lung, M. L.
  3. Cancer Letters. 2006, Mar; 234(2): 184-192.
  1. 5.   Transduction of the gene coding for a human G-protein coupled receptor FPRL1 in mouse tumor cells increases host anti-tumor immunity
  2. Hu, J. Y.; Li, G. C.; Tong, Y. Q.; Li, Y. H.; Zhou, G. H.; He, X. J.; Xie, P. L.; Wang, J. M.; Sun, Q. B.
  3. International Immunopharmacology. 2005, JUN; 5(6): 971-980.
  1. 6.   Formylpeptide receptor FPR and the rapid growth of malignant human gliomas
  2. Zhou, Y.; Bian, X. W.; Le, Y. Y.; Gong, W. H.; Hu, J. Y.; Zhang, X.; Wang, L. H.; Iribarren, P.; Salcedo, R.; Howard, O. M. Z.; Farrar, W.; Wang, J. M.
  3. Journal of the National Cancer Institute. 2005, JUN 1; 97(11): 823-835.
  1. 7.   5-Lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking
  2. Catalano, A.; Caprari, P.; Soddu, S.; Procopio, A.; Romano, M.
  3. Faseb Journal. 2004, SEP; 18(12): Published online only.
  1. 8.   Reduced Fhit protein expression in nickel-transformed mouse cells and in nickel-induced murine sarcomas
  2. Kowara, R.; Salnikow, K.; Diwan, B. A.; Bare, R. M.; Waalkes, M. P.; Kasprzak, K. S.
  3. Molecular and Cellular Biochemistry. 2004 255(1-2): 195-202.
  1. 9.   Suppression of tumor growth and cell proliferation by p13(II), a mitochondrial protein of human T cell leukemia virus type 1
  2. Silic-Benussi, M.; Cavallari, L.; Zorzan, T.; Rossi, E.; Hiraragi, H.; Rosato, A.; Horie, K.; Saggioro, D.; Lairmore, M. D.; Willems, L.; Chieco-Bianchi, L.; D'Agostino, D. M.; Ciminale, V.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(17): 6629-6634.
  1. 10.   Critical prosurvival roles for C/EBP beta and insulin-like growth factor I in macrophage tumor cells
  2. Wessells, J.; Yakar, S.; Johnson, P. F.
  3. Molecular and Cellular Biology. 2004 24(8): 3238-3250.
  1. 11.   In vitro inhibition of the enzymatic activity of tumor suppressor FHIT gene product by carcinogenic transition metals
  2. Kowara, R.; Karaczyn, A. A.; Fivash, M. J.; Kasprzak, K. S.
  3. Chemical Research in Toxicology. 2002 15(3): 319-325.
  1. 12.   A novel germ line juxtamembrane Met mutation in human gastric cancer
  2. Lee, J. H.; Han, S. U.; Cho, H.; Jennings, B.; Gerrard, B.; Dean, M.; Schmidt, L.; Zbar, B.; Vande Woude, G. F.
  3. Oncogene. 2000 19(43): 4947-4953.
  1. 13.   Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells
  2. Salcedo, R.; Resau, J. H.; Halverson, D.; Hudson, E. A.; Dambach, M.; Powell, D.; Wasserman, K.; Oppenheim, J. J.
  3. Faseb Journal. 2000 14(13): 2055-2064.
  1. 14.   Quantitative reactions of anti 5,9-dimethylchrysene dihydrodiol epoxide with DNA and deoxyribonucleotides
  2. Szeliga, J.; Amin, S.
  3. Chemico-Biological Interactions. 2000 128(3): 159-172.
  1. 15.   Regulation of P311 expression by Met-hepatocyte growth factor/scatter factor and the ubiquitin/proteasome system
  2. Taylor, G. A.; Hudson, E.; Resau, J. H.; Vande Woude, G. F.
  3. Journal of Biological Chemistry. 2000 275(6): 4215-4219.
  1. 16.   The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-Met-urokinase plasminogen activator-plasmin proteolytic network
  2. Webb, C. P.; Hose, C. D.; Koochekpour, S.; Jeffers, M.; Oskarsson, M.; Sausville, E.; Monks, A.; Vande Woude, G. F.
  3. Cancer Research. 2000 60(2): 342-349.
  1. 17.   Alteration of Met protooncogene product expression and prognosis in breast carcinomas
  2. Tsarfaty, I.; Alvord, W. G.; Resau, J. H.; Altstock, R. T.; Lidereau, R.; Bieche, I.; Bertr, F.; Horev, J.; Klabansky, R. L.; Keydar, I.; Vande Woude, G. F.
  3. Analytical and Quantitative Cytology and Histology. 1999 21(5): 397-408.
  1. 18.   Effect of Oncogene Expression On Telomerase Activation and Telomere Length in Human Endothelial, Fibroblast and Prostate Epithelial Cells
  2. Burger, A. M.; Fiebig, H. H.; Kuettel, M. R.; Lautenberger, J. A.; Kung, H. F.; Rhim, J. S.
  3. International Journal of Oncology. 1998 13(5): 1043-1048.
  1. 19.   Evidence For a Role of Met-Hgf/Sf During Ras-Mediated Tumorigenesis/Metastasis
  2. Webb, C. P.; Taylor, G. A.; Jeffers, M.; Fiscella, M.; Oskarsson, M.; Resau, J. H.; Woude, G. F. V.
  3. Oncogene. 1998 17(16): 2019-2025.
  1. 20.   Dispensability of P53 Degradation For Tumorigenicity and Decreased Serum Requirement of Human Papillomavirus Type 16e6
  2. Inoue, T.; Oka, K.; Yongil, H.; Vousden, K. H.; Kyo, S.; Jing, P.; Hakura, A.; Yutsudo, M.
  3. Molecular Carcinogenesis. 1998 21(3): 215-222.
  1. 21.   Mechanism of Differential Catalytic Efficiency of Two Polymorphic Forms of Human Glutathione S-Transferase P1-1 in the Glutathione Conjugation of Carcinogenic Diol Epoxide of Chrysene
  2. Hu, X.; Ji, X. H.; Srivastava, S. K.; Xia, H.; Awasthi, S.; Nanduri, B.; Awasthi, Y. C.; Zimniak, P.; Singh, S. V.
  3. Archives of Biochemistry and Biophysics. 1997 345(1): 32-38.
  1. 22.   Activating Mutations For the Met Tyrosine Kinase Receptor in Human Cancer
  2. Jeffers, M.; Schmidt, L.; Nakaigawa, N.; Webb, C. P.; Weirich, G.; Kishida, T.; Zbar, B.; Vande Woude, G. F
  3. Proceedings of the National Academy of Sciences of the United States of America. 1997 94(21): 11445-11450.
  1. 23.   Application of Mixed Mobile Phases and a Step Gradient Method in Capillary Electrochromatography For the Separation of Isomeric Polycyclic Aromatic Hydrocarbon-Deoxyribonucleoside Adduct Mixtures Prepared in Vitro
  2. Ding, J. M.; Szeliga, J.; Dipple, A.; Vouros, P.
  3. Journal of Chromatography. 1997 781(1-2): 327-334.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel